Free Trial

OncoCyte (OCX) News Today

OncoCyte logo
$2.81 -0.11 (-3.77%)
As of 12:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
OncoCyte Co. stock logo
OncoCyte Co. (NASDAQ:OCX) Sees Large Growth in Short Interest
OncoCyte Co. (NASDAQ:OCX - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 373,800 shares, an increase of 22.4% from the February 28th total of 305,500 shares. Approximately 2.5% of the company's stock are sold short. Based on an average daily volume of 89,700 shares, the short-interest ratio is currently 4.2 days.
OncoCyte Co. (NASDAQ:OCX) Short Interest Update
StockNews.com Begins Coverage on OncoCyte (NASDAQ:OCX)
OncoCyte Co. stock logo
OncoCyte (NASDAQ:OCX) Earns Sell Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of OncoCyte in a research note on Monday. They set a "sell" rating on the stock.
OncoCyte files to sell 10.61M shares of common stock for holders
OncoCyte Co. stock logo
OncoCyte Co. (NASDAQ:OCX) Shares Acquired by Pura Vida Investments LLC
Pura Vida Investments LLC boosted its stake in OncoCyte Co. (NASDAQ:OCX - Free Report) by 32.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 654,451 shares of the company's stock after
OncoCyte Co. stock logo
OncoCyte (NASDAQ:OCX) Coverage Initiated by Analysts at Lake Street Capital
Lake Street Capital began coverage on shares of OncoCyte in a research note on Friday. They issued a "buy" rating and a $5.00 price objective for the company.
OncoCyte initiated with a Buy at Lake Street
OncoCyte Co. stock logo
OncoCyte's (OCX) Equal Weight Rating Reiterated at Stephens
Stephens restated an "equal weight" rating and issued a $4.00 target price on shares of OncoCyte in a research note on Tuesday.
OncoCyte Co. stock logo
OncoCyte's (OCX) "Buy" Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC restated a "buy" rating and set a $4.25 target price on shares of OncoCyte in a research note on Tuesday.
OncoCyte (NASDAQ:OCX) Given "Equal Weight" Rating at Stephens
OncoCyte Co. stock logo
OncoCyte (NASDAQ:OCX) Announces Earnings Results
OncoCyte (NASDAQ:OCX - Get Free Report) announced its earnings results on Monday. The company reported $0.48 earnings per share for the quarter. OncoCyte had a negative net margin of 6,122.29% and a negative return on equity of 269.32%.
OncoCyte Co. stock logo
OncoCyte (NASDAQ:OCX) Trading Up 14.7% - Should You Buy?
OncoCyte (NASDAQ:OCX) Trading Up 14.7% - Here's Why
Oncocyte corp CFO buys $200,000 in stock
Oncocyte Prices $29.1 Million Equity Offering
Insider Stock Buying Reaches US$508.4k On OncoCyte
OncoCyte appoints Billings as consulting CMO
OncoCyte announces publication of DetermaCNI assay data
OncoCyte announces VitaGraft data published in journal
OncoCyte Corp Reports Q3 2024 Earnings and Strategic Updates
OncoCyte’s Strategic Advances and Financial Prudence Justify Buy Rating
Remove Ads
Get OncoCyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCX and its competitors with MarketBeat's FREE daily newsletter.

OCX Media Mentions By Week

OCX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OCX
News Sentiment

0.42

0.61

Average
Medical
News Sentiment

OCX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OCX Articles
This Week

11

2

OCX Articles
Average Week

Remove Ads
Get OncoCyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:OCX) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners